Inventor · disambiguated record
Philip Michael Reaper
Also filed as: REAPER PHILIP · REAPER PHILIP M · REAPER PHILIP MICHAEL
20 granted patents·14 pending applications·356 citations·filing 2004–2022
96Inventor score
Top patents by PatentIndex Score
34 records- 0198US9701674B2Substituted pyrazines as ATR kinase inhibitorsVERTEX PHARMA·Filed 2014·Granted Jul 11, 2017·22 cites·61 claims
- 0298US9365557B2Substituted pyrazin-2-amines as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted Jun 14, 2016·27 cites·54 claims
- 0398US8841308B2Pyrazin-2-amines useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2009·Granted Sep 23, 2014·54 cites·11 claims
- 0497US8962631B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Feb 24, 2015·31 cites·32 claims
- 0597US8410112B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Apr 2, 2013·56 cites·71 claims
- 0695US9791456B2Method for measuring ATR inhibition mediated increases in DNA damageVERTEX PHARMA·Filed 2015·Granted Oct 17, 2017·17 cites·17 claims
- 0795US8999632B2Method for measuring ATR inhibition mediated increases in DNA damageVERTEX PHARMA·Filed 2013·Granted Apr 7, 2015·40 cites·5 claims
- 0895US8969356B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Mar 3, 2015·18 cites·37 claims
- 0994US9334244B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted May 10, 2016·12 cites·19 claims
- 1093US8623869B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Jan 7, 2014·20 cites·42 claims
- 1192US9096584B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Aug 4, 2015·18 cites·11 claims
- 1291US10479784B2Substituted pyrazin-2-amines as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2018·Granted Nov 19, 2019·3 cites·10 claims
- 1390US9062008B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Jun 23, 2015·14 cites·2 claims
- 1490US8877759B2Aminopyrazines as ATR kinase inhibitorsCHARRIER JEAN-DAMIEN·Filed 2012·Granted Nov 4, 2014·16 cites·34 claims
- 1587US10961232B2Substituted pyrazines as ATR kinase inhibitorsVERTEX PHARMA·Filed 2017·Granted Mar 30, 2021·2 cites·24 claims
- 1684US11110086B2Compounds useful as inhibitors of ATR kinase and combination therapies thereofVERTEX PHARMA·Filed 2019·Granted Sep 7, 2021·1 cites·20 claims
- 1784US10813929B2Treating cancer with ATR inhibitorsVERTEX PHARMA·Filed 2014·Granted Oct 27, 2020·2 cites·1 claims
- 1881US10478430B2Compounds useful as inhibitors of ATR kinase and combination therapies thereofVERTEX PHARMA·Filed 2015·Granted Nov 19, 2019·3 cites·20 claims
- 1975US2023030414A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2071US2022233521A1Compounds useful as inhibitors of atr kinase and combination therapies thereofVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2165US2023106592A1Method for treating cancer using a combination of dna damaging agents and atr inhibitorsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2265US2020390761A1Treating cancer with atr inhibitorsVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 2363US2016311809A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2016·Application pending·0 cites
- 2463US2014288347A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2557US2014044802A1Compounds useful as inhibitors of atr kinase and combination therapies thereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2655US11464774B2Method for treating cancer using a combination of DNA damaging agents and ATR inhibitorsVERTEX PHARMA·Filed 2016·Granted Oct 11, 2022·0 cites·14 claims
- 2755US2015239874A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2854US2016271129A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2016·Application pending·0 cites
- 2949US2014113005A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 3049US2016009723A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3149US2007099186A1Methods and means for the treatment of disorders associated with cellular senescenceD ADDA DI FAGAGNA FABRIZIO·Filed 2004·Application pending·0 cites
- 3248US2013089626A1Treating Cancer with ATR InhibitorsPOLLARD JOHN ROBERT·Filed 2012·Application pending·0 cites
- 3346US2021196751A1Methods of cancer treatment using an atr inhibitorVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 3438US9630956B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Apr 25, 2017·0 cites·36 claims
Join the waitlist — get patent alerts
Get an alert when Philip Michael Reaper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →